Grasslanz Technology Australia Pty Limited
White clover (Trifolium repens L.)
Altered condensed tannin concentration, Selectable marker – antibiotic
This licence allows Grasslanz Technology Australia Pty Limited (GT Australia) to grow field trials of white clover genetically modified for increased condensed tannins in the leaves. Higher condensed tannins may help to prevent bloat in grazing animals and may also help manage greenhouse gas emissions. The GM white clover may be grown at up to four sites per year with a maximum area across all sites of 1 ha per year. Individual sites would be no larger than 0.3 ha.
The aim of the trial is to assess how the GM white clover performs under field conditions. The GM white clover grown in the field trial will not be used in human food or animal feed. GT Australia must comply with a range of licence conditions that restrict when and where the trial can take place, limit the size of the trial, and stop GM white clover from spreading outside the trial.
The risk analysis for this application was carried out in accordance with the Regulator’s Risk Analysis Framework.
You can find out more about white clover and how it is farmed in Australia in our biology document.
Outlines the Regulator’s decision to issue a licence following the assessment of this application.
FAQs on the licence application and the Regulator’s decision to issue a licence for this application.
A summary of the Risk Assessment and Risk Management Plan prepared as part of the assessment of this application. It provides a brief description of the licence application, the risk assessment and risk management plan.
The final risk assessment and management plan prepared to support the Regulator's decision. It describes the GMO(s) and proposed work with the GMO(s) and provides an assessment of potential risks posed by the GMO(s). It also includes a summary of submissions received during the public consultation process.